Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher tous les synonymes
Sélectionnez vos espèces d'intérêt
Human EGFR Protein expressed in HEK-293 Cells - ABIN2180999
Fazekas-Singer, Berroterán-Infante, Rami-Mark, Dumanic, Matz, Willmann, Andreae, Singer, Wadsak, Mitterhauser, Jensen-Jarolim: Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials. dans Oncotarget 2017
Human EGFR Protein expressed in Human Cells - ABIN2001843
Schlessinger: Cell signaling by receptor tyrosine kinases. dans Cell 2000
Show all 4 Pubmed References
Human EGFR Protein expressed in HEK-293 Cells - ABIN2181000
Singer, Fazekas, Wang, Weichselbaumer, Matz, Mader, Steinfellner, Meitz, Mechtcheriakova, Sobanov, Willmann, Stockner, Spillner, Kunert, Jensen-Jarolim: Generation of a canine anti-EGFR (ErbB-1) antibody for passive immunotherapy in dog cancer patients. dans Molecular cancer therapeutics 2014
Human EGFR Protein expressed in Wheat germ - ABIN1352437
Zheng, Zhang, Croucher, Soliman, St-Denis, Pasculescu, Taylor, Tate, Hardy, Colwill, Dai, Bagshaw, Dennis, Gingras, Daly, Pawson: Temporal regulation of EGF signalling networks by the scaffold protein Shc1. dans Nature 2013
Human EGFR Protein expressed in Insect cells (Sf9) - ABIN2720019
Chaudhary, Thamake, Shetty, Vishwanatha: Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies. dans British journal of cancer 2014
Human EGFR Protein expressed in HEK-293 Cells - ABIN5674594
Yu, Pegram, Bigner, Chandramohan: Development and validation of a cell-based fluorescent method for measuring antibody affinity. dans Journal of immunological methods 2017
Results indicated that most periocular squamous cell carcinomas of horses expressed epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2 (Montrer ERBB2 Protéines)).
Graf (Montrer ARHGAP26 Protéines) functions to downregulate EGFR signaling.
Data show that EGFR controls the proper formation of brain neuroblasts by regulating the number, survival and proneural gene expression of neuroectodermal progenitor cells which suggest that EGFR signalling is crucially important for patterning and early neurogenesis of the brain.
The activity of Gro (Montrer CXCL1 Protéines) is antagonized by EGFR signaling, which inhibits Gro (Montrer CXCL1 Protéines)-dependent repression via p-ERK (Montrer MAPK1 Protéines) mediated phosphorylation.
These results reveal that ESCRT-0 (ESCRT-0 components stam (Montrer STAM Protéines) and hrs)mutants inhibit EGFR signaling by disrupting Rhomboid endosomal trafficking in the ligand-producing cells.
we find that EGFR regulates the apical determinant Crb and the extracellular matrix regulator Serp, two factors previously known to control tube length. EGFR regulates the organisation of endosomes in which Crb and Serp proteins are loaded
Here we uncover a cell non-autonomous requirement for the Epidermal growth factor receptor (Egfr) pathway in the lateral epidermis for sustained dpp (Montrer TGFb Protéines) expression in the LE. Specifically, we demonstrate that Egfr pathway activity in the lateral epidermis prevents expression of the gene scarface (scaf), encoding a secreted antagonist of JNK (Montrer MAPK8 Protéines) signaling
Loss of Usp5 (Montrer USP5 Protéines) results in upregulation of Notch (Montrer NOTCH1 Protéines) signaling and downregulation of RTK signaling by EGF receptor (EGFR) and Sevenless (Sev), leading to impaired photoreceptor development.
These data demonstrate a strong genetic link between dG9a and the EGFR signaling pathway.
Avermectin directly interacts with EGFR and leads to the activation of the EGFR/AKT (Montrer AKT1 Protéines)/ERK (Montrer MAPK1 Protéines) pathway.
The dorsoventral patterning and EGFR signaling genes play essential roles in correct identity determination and differentiation of lateral glia in the Drosophila nervous system.
Study demonstrated that IGF-I (Montrer IGF1 Protéines) can stimulate egfr expression in both follicles cell culture and intact follicles promoting oocyte maturation.
These results indicate that maintenance of Pgrmc1 signaling is required for Egfr expression on zebrafish oocyte cell membranes and for conserving the functions of Egfr in maintaining meiotic arrest through estrogen activation of Gper.
EGFR signaling in vertebrate oocytes can prevent meiotic progression.
the expression of EGFR was mainly restricted to the follicle cells with little expression in the oocytes
EGFR gene amplification and mutations are rare in triple-negative breast cancer (TNBC), the latter of no apparent clinical relevance. Surrogate markers of EGFR-related chromosomal aberrations and combined EGFR/p53 (Montrer TP53 Protéines) IHC phenotypes appear to be associated with favorable prognosis in patients with operable TNBC receiving conventional adjuvant chemotherapy.
EGFR gene copy number is a biomarker for response to EGFR-tyrosine kinase (Montrer TXK Protéines) inhibitor therapy in patients with advanced non-small-cell lung cancer.
Osimertinib reduces PD-L1 (Montrer CD274 Protéines) mRNA expression and induces its protein degradation, suggesting that osimertinib may reactivate the immune activity of T cells in the tumor microenvironment in EGFR-mutated NSCLC patients.
There is a higher incidence of brain metastases for patients with EGFR+ metastatic non-small cell lung cancer, even when adjusted for differences in survival, compared to EGFR wild type.
EGFR expression was associated with shorter cancer-specific overall survival. Our finding suggests EGFR is a useful prognostic marker of patients with distal extrahepatic bile duct (EBD (Montrer DEFB1 Protéines)) carcinoma.
MET/T790M-positive patients are at higher risk of acquired resistance to EGFR-Tyrosine kinase (Montrer TXK Protéines) inhibitors, and have a worse Post-progression survival than patients with only MET overexpression or the T790M mutation alone. Clinical trials are needed to determine the best treatment for patients with both MET overexpression and the EGFR T790M mutation.
the EGFR/STAT3 (Montrer STAT3 Protéines) pathway contributed to CDDP-induced CEBPD (Montrer CEBPD Protéines) expression in UCUB cells. Gefitinib and S3I-201 treatment significantly reduced the expression of CEBPD (Montrer CEBPD Protéines) and enhanced the sensitivity of CDDP-resistant UCUB cells to CDDP and paclitaxel
EGFR rs11506105 is strongly associated with treatment responses in Iranian patients with chronic hepatitis C.
EGR1 (Montrer EGR1 Protéines) is a key player in the transcriptional control of miR (Montrer MLXIP Protéines)-203a, and that miR (Montrer MLXIP Protéines)-203a acts as an anti-oncogene (Montrer RAB1A Protéines) to suppress HCC (Montrer FAM126A Protéines) tumorigenesis by targeting HOXD3 (Montrer HOXD3 Protéines) through EGFR-related cell signaling pathways.
The long noncoding RNA CAR intergenic 10 bound and stabilized transcription factor Y-box-binding protein 1 (YB-1 (Montrer YBX1 Protéines)), leading to up-regulation of the epidermal growth factor receptor (EGFR) and proliferation of lung cancer cells.
These results suggest that EphA2/Efna1/Egfr genes, linked to a possible control by miR-200a and miR-26b, could be proposed as novel CRC prognostic biomarkers. Moreover, EphA2 could be linked to a mechanism of resistance to cetuximab alternative to KRAS mutations.
These results collectively suggest that sustained activation of Wnt (Montrer WNT2 Protéines)/beta-catenin (Montrer CTNNB1 Protéines) signaling in endothelial cells might be a cause of heart failure through suppressing neuregulin-ErbB signaling.
Epidermal growth factor receptor (EGFR) signaling enhances miR (Montrer MLXIP Protéines)-29 expression in glioblastoma cells via upregulation of Sterol regulatory element binding protein 1 (Montrer SREBF1 Protéines)
YAP (Montrer YAP1 Protéines) accumulated in nuclei of mammary glands in ErbB2 (Montrer ERBB2 Protéines)/EGFR-transgenic mice, suggesting that EGFR signaling affects YAP (Montrer YAP1 Protéines) in vivo similar to cell culture. ErbB2 (Montrer ERBB2 Protéines)/EGFR-transgenic mice develop mammary tumors in 7-8 months, but surprisingly, MaSCs from these mice did not form tumors when transplanted into host mice.
Findings suggest that sEGFR might be a biomarker for evaluating insulin (Montrer INS Protéines) resistance or a therapeutic target of liraglutide.
Xenoestrogens biphenol-A and nonylphenol stimulate the release of EGFR-ligands by differentially activating ADAM17 (Montrer ADAM17 Protéines) or ADAM10 (Montrer ADAM10 Protéines).
Data suggest that simultaneous inhibition of mTOR (Montrer FRAP1 Protéines) and EGFR or MEK (Montrer MDK Protéines) may be more effective in treating colon cancer.
Data indicate alpha-P85 (Montrer ECM1 Protéines) Subunit, PI-3K (p85alpha) as a positive regulator of epidermal growth factor receptor (EGFR) expression and cell malignant transformation via nucleolin (Montrer NCL Protéines)-dependent mechanism.
through the activation of EGFR, MET activation parallels a RAS pathway to contribute to human and mouse cutaneous cancers.
OLIG2 (Montrer OLIG2 Protéines) modulates growth factor signaling in two distinct populations of glioma stem cells, characterized by expression of either the epidermal growth factor receptor (EGFR) or platelet-derived growth factor receptor alpha (Montrer PDGFRA Protéines).
this study shows that anemonin may ameliorate LPS (Montrer IRF6 Protéines)-induced intestinal injury and improve restoration by regulating the TGF-b1 and EGFR signaling pathways
Syndecan-4 (Montrer SDC4 Protéines) mediates porcine respiratory and reproductive syndrome virus entry by interacting with EGFR.
These results indicate that cAMP and oocyte-secreted factors cooperate to promote EGF receptor functionality in developing cumulus oocyte complexes, representing a key component of the acquisition of oocyte developmental competence.
patients experiencing gefitinib dose reduction or short-term treatment interruption due to toxicities did not show inferior survival, compared to those receiving full dose of gefitinib in non-small cell lung cancer patients with EGFR mutation
Report EGFR expression in the normal pancreas.
Injury and activation of purinergic receptors and direct activation of EGFR via EGF (Montrer EGF Protéines) induce distinct downstream pathways.
Data suggest that the mechanism of hypoxia-induced increased activation of EGFR kinase is mediated by nNOS (Montrer NOS1 Protéines)-derived nitric oxide.
EGFR, VEGFR (Montrer KDR Protéines) and FGFR (Montrer FGFR2 Protéines) are expressed in porcine oviduct and endometrium during the time of implantation [review]
the restricted presence of the functional full-size receptor to the epithelial layer indicates a specific role during early embryonic development, whereas truncated EGF-R forms may potentially regulate contractions and blood flow in the oviduct
The phase-related expression of EGF (Montrer EGF Protéines) and EGFR in the endothelium of the uterine artery and its branches suggest the modulatory effect of EGF (Montrer EGF Protéines) and its receptor on the uterine artery and the region supplying these vessels.
Stimulation of bovine oviduct epithelial cell EGFR with EGF (Montrer EGF Protéines) (human recombinant EGF (Montrer EGF Protéines)) alone or with EGF (Montrer EGF Protéines) in postovulatory/follicular phases (not luteal phase) up-regulates phosphorylation of MAPKs; heat blocks effects of EGF (Montrer EGF Protéines) on phosphorylation of MAPKs.
Expression of the erbB/HER receptor family in the bovine uterus during the sexual cycle and the relation of this family to serum sex steroids.
Regulation of the sperm EGFR by ouabain leads to initiation of the acrosome reaction.
EGFR may simultaneously activate c-Src (Montrer SRC Protéines) and PI3K to amplify the oxytocin signaling to increase the output of PGF (Montrer PGF Protéines)(2 alpha) in endometrial epithelial cells.
results indicate that arginase induction depends in part on epidermal growth factor (EGF (Montrer EGF Protéines)) receptor activity, and that EGFR inhibitors may attenuate vascular remodeling without affecting nitric oxide release
Data suggest that epidermal growth factor (EGF (Montrer EGF Protéines)) and EGF (Montrer EGF Protéines) receptors are important paracrine and/or autocrine regulators of spermatogenesis in bovine.
MT1-MMP (Montrer MMP14 Protéines) has a role in signaling events mediating EGFR transactivation
possible cooperative role of the EGF (Montrer EGF Protéines) and HGF (Montrer HGF Protéines) pathways and indicate that cross-talk between their respective receptors may modulate mammary gland development in the cow
EGFR is stimulated during capacitation via PKA activation. More activation induces the acrosome reaction, which is induced by GPCR via EGFR transactivation by a signaling pathway involving PKA, SRC & metalloproteinase & effectors PI3K, PLC & PKC.
The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. Multiple alternatively spliced transcript variants that encode different protein isoforms have been found for this gene.
, Egf receptor
, drosophila epidermal growth factor receptor homologue
, ellipse torpedo
, epidermal growth factor receptor
, faint little ball
, morphological defects 1
, avian erythroblastic leukemia viral (v-erb-b) oncogene homolog
, cell growth inhibiting protein 40
, cell proliferation-inducing protein 61
, proto-oncogene c-ErbB-1
, receptor tyrosine-protein kinase erbB-1
, EGFR-related peptide
, Epidermal growth factor receptor formerly avian erythroblastic leukemia viral (v-erbB) oncogene homolog (Erbb1)
, avian erythroblastic leukemia viral (v-erbB) oncogene homolog
, epidermal growth factor receptor, formerly avian erythroblastic leukemia viral (v-erbB) oncogene homolog (Erbb1)
, waved 2
, epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
, egf receptor
, receptor tyrosine kinase ErbB1